

Astral Codex Ten Podcast
Jeremiah
The official audio version of Astral Codex Ten, with an archive of posts from Slate Star Codex. It's just me reading Scott Alexander's blog posts.
Episodes
Mentioned books

12 snips
Oct 5, 2025 • 37min
Your Review: The Russo-Ukrainian War
A poignant narrative unfolds as a volunteer recounts leaving a mundane IT job to fight in the Russo-Ukrainian War. From navigating recruitment challenges to the vibrant chaos of Lviv, the author captures wartime realities. He shares insights into Ukrainian national identity, life on the frontlines, and the evolving nature of modern combat with drones. Themes of honor, camaraderie, and the personal motivations of foreign fighters paint a compelling picture of resilience amid chaos.

Oct 5, 2025 • 19min
Sources Say Bay Area House Party
A satirical Bay Area house party takes a wild turn with the concept of curtfishing, where men claim ties to Curtis Yarvin to attract female journalists. Hilarious impersonations and networking attempts spark awkward interactions, while Caitlin pitches a service for crafting public condemnations. A dubious startup linking hitmen and witches adds to the chaos, and discussions on the erosion of shock value in language ensue. Ramchandra's bizarre rants and social media's influence bring a surreal edge to the night.

Sep 26, 2025 • 50min
Your Review: Project Xanadu - The Internet That Might Have Been
Explore Vannevar Bush's visionary concept of the Memex, a revolutionary mechanized library ahead of its time. Dive into Doug Engelbart's famous 1968 demo showcasing hypermedia and collaboration tools. Discover Ted Nelson’s ambitious Project Xanadu and the philosophical debates around hypertext. Uncover why the World Wide Web triumphed over Xanadu despite its richer features, and examine what the Web missed. Finally, contemplate Xanadu's legacy and the quirks of its prolonged development journey.

Sep 26, 2025 • 9min
Defining Defending Democracy: Contra The Election Winner Argument
The discussion dives into whether favoring election winners over unelected institutions is truly undemocratic. It argues that democracy thrives on multiple elections, not just one. An independent judiciary is highlighted as vital for accountability. The need for a robust press is emphasized to ensure informed public protest. Whistleblowers and NGOs play critical roles in safeguarding elections. Lastly, the podcast presents a compelling case on how undermining institutions threatens future democratic processes.

44 snips
Sep 24, 2025 • 1h 6min
Your Review: The Synaptic Plasticity and Memory Hypothesis
Dive into the intriguing rituals of the Tupinambá, where captives faced elaborate cannibalism ceremonies observed by explorer Hans Staden. Explore why these warriors might have believed that consuming enemies conferred strength. Transitioning to modern science, discover the fascinating ideas surrounding heart transplants and reported recipient personality changes. The discussion ventures into the nuances of synaptic plasticity, debating whether these changes are necessary or sufficient for memory, backed by historical insights and intriguing biological perspectives.

44 snips
Sep 12, 2025 • 42min
Book Review: If Anyone Builds It, Everyone Dies
Dive into the intriguing world of AI safety as one organization challenges the status quo with their stark moral clarity. Discover the alarming implications of artificial intelligence and the public's unawareness of its risks. Explore critical global issues like climate change and the necessity for urgent action. Engage with imaginative narratives highlighting the competition among life forms and the dangers of AI misalignment. Unpack strategies for raising public awareness on the potential threat of superhuman AI through compelling storytelling.

Sep 10, 2025 • 25min
Your Review: Participation in Phase I Clinical Pharmaceutical Research
[This is one of the finalists in the 2025 review contest, written by an ACX reader who will remain anonymous until after voting is done. I’ll be posting about one of these a week for several months. When you’ve read them all, I’ll ask you to vote for a favorite, so remember which ones you liked] If you’ve been following this blog for long, you probably know at least a bit about pharmaceutical research. You might know a bit about the sort of subtle measures pharmaceutical companies take to influence doctors’ prescribing habits, or how it takes billions of dollars on average to bring a new medication to market, or something about the perverse incentives which determine the FDA’s standards for accepting or rejecting a new drug. You might have some idea what kinds of hoops a company has to jump through to conduct actual research which meets legal guidelines for patient safety and autonomy. You may be less familiar though, with how the sausage is actually made. How do pharmaceutical companies actually go through the process of testing a drug on human participants? I’m going to be focusing here on a research subject’s view of what are known as Phase I clinical trials, the stage in which prospective drugs are tested for safety and tolerability. This is where researchers aim to answer questions like “Does this drug have any dangerous side effects?” “Through what pathways is it removed from a patient’s body?” and “Can we actually give people enough of this drug that it’s useful for anything?” This comes before the stage where researchers test how good a drug is at actually treating any sort of disease, when patients who’re suffering from the target ailments are given the option receive it as an experimental treatment. In Phase I clinical trials, the participants are healthy volunteers who’re participating in research for money. There are almost no cases in which volunteer participation is driven by motivations other than money, because the attitudes between research participants and clinicians overwhelmingly tend to be characterized by mutual guarded distrust. This distrust is baked into the process, both on a cultural level among the participants, and by the clinics’ own incentives. All of what follows is drawn from my own experiences, and experiences that other participants in clinical pharmaceutical research have shared with me, because for reasons which should become clear over the course of this review, research which systematically explores the behaviors and motives of clinical research participants is generally not feasible to conduct. https://www.astralcodexten.com/p/your-review-participation-in-phase

Sep 10, 2025 • 44min
Links For September 2025
Dive into fascinating discussions about human genome mapping and the impact of social media on mental health. Explore the complexities of consciousness, AI's effects on various fields, and the intriguing insights from twin studies. Delve into quirky AI narratives and unexpected cultural anecdotes. Unpack mental health commitments and the complexities of consent laws, while navigating the politics of adulthood. Conclude with predictions on political unrest and compelling debates surrounding basic income and urban planning in African cities.

20 snips
Sep 10, 2025 • 15min
What Is Man, That Thou Art Mindful Of Him?
Dive into a fascinating discussion about the limits of human intelligence, especially in mathematical reasoning. Hear intriguing hypothetical scenarios that challenge our cognitive boundaries. The conversation also delves into the moral dilemmas tied to biological intelligence evolution, weighing the benefits of growth against potential dangers. Engage with thought-provoking ideas about our understanding of intelligence and the ethical implications of its enhancement.

Sep 2, 2025 • 5min
Open Letter To The NIH
In an urgent call for action, scientists and healthcare professionals push for the NIH to allocate $5 billion for crucial medical research. They stress the importance of spending appropriated funds effectively before the fiscal year ends. The discussion reveals concerns about potential retaliation against critics and the need for a unified voice in demanding accountability. This collective effort aims to promote biomedical advancements and ensure that vital research funding isn't lost.